As American workers enroll in health plans this fall, fewer will find that their employers cover GLP-1 drugs for weight loss.

The share of U.S. companies covering the medications for weight loss in their employee health insurance plans fell to 53% this year, according to a survey of nearly 500 companies by consultancy WTW. That marks the first decline in coverage since the drugs became widely used for weight loss three years ago. And the pullback may not be over: 30% of the companies that still cover the pricey medications are considering dropping them, the survey found.

By comparison, 57% of U.S. employers covered the medications in 2025, WTW found.

Lowe’s Cos., PepsiCo Inc., PricewaterhouseCoopers LLP, Starbucks Corp. and Cigna Group are among the companies that have stopped funding employees’ GLP-1 medications as rising healthcare costs prompt employers to rethink their benefits offerings.…